Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Early Diagnosis and Staging.

H Lilja1, D R H Lilja

  • 1Department of Laboratory Medicine, Division of Clinical Chemistry, Lund University, University Hospital, Malmö, S-205 Malmö, Sweden.

Prostate Cancer and Prostatic Diseases
|December 24, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Composite Functional and Quality of Life Outcomes in Adults Operated for Cloacal Malformation.

Journal of pediatric surgery·2024
Same author

The role of plasma microseminoprotein-beta in prostate cancer: an observational nested case-control and Mendelian randomization study in the European prospective investigation into cancer and nutrition.

Annals of oncology : official journal of the European Society for Medical Oncology·2019
Same author

An analysis of the association between prostate cancer risk loci, PSA levels, disease aggressiveness and disease-specific mortality.

British journal of cancer·2015
Same author

miR-205 negatively regulates the androgen receptor and is associated with adverse outcome of prostate cancer patients.

British journal of cancer·2013
Same author

Integrated acoustic immunoaffinity-capture (IAI) platform for detection of PSA from whole blood samples.

Lab on a chip·2013
Same author

Soluble urokinase plasminogen activator receptor as a prognostic marker in men participating in prostate cancer screening.

Journal of internal medicine·2010

This review covers advancements in early prostate cancer diagnosis and staging, evaluating population-based screening

Area of Science:

  • Urology
  • Oncology
  • Medical Diagnostics

Background:

  • Prostate cancer incidence and the need for accurate early detection methods.
  • Challenges in current prostate cancer staging and diagnosis.

Purpose of the Study:

  • To review recent developments in early prostate cancer diagnosis and staging.
  • To discuss the advantages and disadvantages of population-based prostate cancer screening.
  • To assess the reliability and refinements of various diagnostic procedures.

Main Methods:

  • Review of current literature on prostate cancer diagnostic techniques.
  • Analysis of PSA testing, transrectal ultrasound, and related biomarkers.
  • Evaluation of predictive models including neural networks and PSA derivatives.

Related Experiment Videos

Main Results:

  • Refined diagnostic procedures improve accuracy in prostate cancer detection.
  • New methods enhance the reliability of staging and likelihood prediction.
  • Biomarkers like percent free PSA and glandular kallikrein 2 offer valuable diagnostic information.

Conclusions:

  • Advancements in diagnostic tools are crucial for early prostate cancer detection.
  • Population-based screening requires careful consideration of its pros and cons.
  • Integrated approaches using multiple biomarkers and predictive models show promise.